Blair William & Co. IL Sells 747,380 Shares of Kenvue Inc. (NYSE:KVUE)

Blair William & Co. IL trimmed its stake in Kenvue Inc. (NYSE:KVUE) by 57.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 563,746 shares of the company’s stock after selling 747,380 shares during the quarter. Blair William & Co. IL’s holdings in Kenvue were worth $10,249,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of the stock. Manchester Capital Management LLC raised its holdings in Kenvue by 80.8% in the 1st quarter. Manchester Capital Management LLC now owns 1,186 shares of the company’s stock worth $25,000 after acquiring an additional 530 shares during the last quarter. Mather Group LLC. bought a new stake in shares of Kenvue in the 1st quarter worth $28,000. Riverview Trust Co purchased a new position in shares of Kenvue in the first quarter worth $33,000. MV Capital Management Inc. lifted its holdings in shares of Kenvue by 71.2% during the first quarter. MV Capital Management Inc. now owns 1,544 shares of the company’s stock valued at $33,000 after purchasing an additional 642 shares in the last quarter. Finally, Salomon & Ludwin LLC bought a new position in shares of Kenvue during the first quarter valued at $33,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. UBS Group boosted their target price on Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Royal Bank of Canada restated an “outperform” rating and issued a $24.00 target price on shares of Kenvue in a report on Wednesday, August 7th. JPMorgan Chase & Co. boosted their target price on shares of Kenvue from $22.00 to $24.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Citigroup dropped their price target on Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $21.44.

Kenvue Stock Performance

NYSE:KVUE opened at $22.90 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.68 and a current ratio of 0.99. The stock has a 50-day simple moving average of $20.83 and a two-hundred day simple moving average of $19.93. The firm has a market capitalization of $43.85 billion, a PE ratio of 29.36, a P/E/G ratio of 2.92 and a beta of 1.40. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $23.55.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. During the same period in the previous year, the company posted $0.32 EPS. The firm’s revenue was down .3% on a year-over-year basis. Analysts forecast that Kenvue Inc. will post 1.08 EPS for the current year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Wednesday, August 14th were given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.58%. This is an increase from Kenvue’s previous quarterly dividend of $0.20. The ex-dividend date was Wednesday, August 14th. Kenvue’s dividend payout ratio (DPR) is presently 105.13%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.